MDMAT

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 15:37, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

MDMAT
Clinical data
Pregnancy
category
  • ?
Routes of
administration
?
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • N-Methyl-5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxol-6-amine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H15NO2
Molar mass205.257 g·mol−1
3D model (JSmol)
  • C3c1cc2OCOc2cc1CCC3NC
  • InChI=1S/C12H15NO2/c1-13-10-3-2-8-5-11-12(15-7-14-11)6-9(8)4-10/h5-6,10,13H,2-4,7H2,1H3 ☒N
  • Key:MTRLJTZQUZHTJI-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

MDMAT (6,7-methylenedioxy-N-methyl-2-aminotetralin) is a putative, non-neurotoxic, selective serotonin releasing agent (SSRA) and entactogen drug. It is the N-methylated derivative of MDAT, similarly to the relationship of MDMA to MDA or MDMAI to MDAI.[1][2] It has been sold online as a recreational drug and research chemical since 2010.

See also

References

  1. ^ Chimica Therapeutica. 6 (3): 196. 1971. {{cite journal}}: Missing or empty |title= (help)
  2. ^ Medicinal Chemistry Research. 6 (6): 412. 1996. {{cite journal}}: Missing or empty |title= (help)